Private Capital Group’s Aerie Pharmaceuticals AERI Stock Holding History

Private Capital Group’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-52	Closed	-$1K	–	2196
2019 Q4	$1K	Buy	+52	New	+$1.08K	﹤0.01%	1894
2019 Q3	–	Sell	-10	Closed	-$1K	–	2501
2019 Q2	$1K	Buy	+10	New	+$385	﹤0.01%	2107
2018 Q3	–	Sell	-10	Closed	–	–	2323
2018 Q2	$0	Hold	10	–	–	﹤0.01%	2290
2018 Q1	$1K	Sell	10 -147	-94%	-$8.22K	﹤0.01%	2055
2017 Q4	$1	Buy	+157	New	+$9.52K	﹤0.01%	1997

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Private Capital Group's AERI Position: Q1 2020 in Review

Private Capital Group sold out of Aerie Pharmaceuticals (AERI) in Q1 2020, closing a stake of 52 shares — an estimated $1K sold.

Private Capital Group first reported a position in AERI in Q4 2017 and held it in 5 quarters. The position peaked at $1K in Q4 2019. 155 funds tracked by Wall St. Rank hold AERI as of Q1 2020.

Private Capital Group reported no remaining Aerie Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Private Capital Group sold 52 Aerie Pharmaceuticals shares in Q1 2020, an estimated $1K.
Private Capital Group first reported a position in Aerie Pharmaceuticals in Q4 2017 and held it in 5 quarters.
Private Capital Group's Aerie Pharmaceuticals position peaked at $1K in Q4 2019.
155 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2020.

Based on Private Capital Group's 13F filing for Q1 2020, filed 7 May 2020.